Antibiotic Resistance Comprehensive Study by Disease (Complicated Urinary Tract Infection {cUTI}, Complicated Intra-Abdominal Infections {cIAI}, Blood Stream Infections {BSI}, Clostridium difficile infections {CDI}, Acute Bacterial Skin and Skin Structure Infections {ABSSSI}, Hospital Acquired Bacterial Pneumonia/Ventilator {HABP/VABP}, Community Acquired Bacterial Pneumonia {CABP}), Pathogen (Acinetobacter baumannii {Carbapenem-Resistant and ESBL-producing}, Pseudomonas aeruginosa {Carbapenem-Resistant}, Staphylococcus Aureus {Methicillin-Resistant}, E. coli/K. pneumoniae {Carbapenem-Resistant}, Streptococcus pneumoniae {Penicillin-Non-Susceptible}, Clostridium difficile {Cephalosporin-Resistant, Tetracycline-Resistant}, Enterococcus faecium {Vancomycin-Resistant}, Haemophilus Influenzae {Ampicillin-Resistant}), Drug Class (Oxazolidinones, Lipoglycopeptides, Tetracyclines, Cephalosporins, Combination therapies, Others) Players and Region - Global Market Outlook to 2030

{reportSlug=global-antibiotic-resistance-market, reportId=89339, mktKeyword=Antibiotic Resistance, cagr=6.18, publishDate=Sep 2024, priceOption2=7500, reportTitle=Antibiotic Resistance Comprehensive Study by Disease (Complicated Urinary Tract Infection {cUTI}, Complicated Intra-Abdominal Infections {cIAI}, Blood Stream Infections {BSI}, Clostridium difficile infections {CDI}, Acute Bacterial Skin and Skin Structure Infections {ABSSSI}, Hospital Acquired Bacterial Pneumonia/Ventilator {HABP/VABP}, Community Acquired Bacterial Pneumonia {CABP}), Pathogen (Acinetobacter baumannii {Carbapenem-Resistant and ESBL-producing}, Pseudomonas aeruginosa {Carbapenem-Resistant}, Staphylococcus Aureus {Methicillin-Resistant}, E. coli/K. pneumoniae {Carbapenem-Resistant}, Streptococcus pneumoniae {Penicillin-Non-Susceptible}, Clostridium difficile {Cephalosporin-Resistant, Tetracycline-Resistant}, Enterococcus faecium {Vancomycin-Resistant}, Haemophilus Influenzae {Ampicillin-Resistant}), Drug Class (Oxazolidinones, Lipoglycopeptides, Tetracyclines, Cephalosporins, Combination therapies, Others) Players and Region - Global Market Outlook to 2030, baseYr=2023, totalTableFig=189, priceOption1=3750, forecastYr=2030, noOfPages=156, reportKey=88897, breadcrum=Global Antibiotic Resistance Market}